Meridian Bioscience Inc. (VIVO)

14.50
0.05 0.34
NASDAQ : Health Technology
Prev Close 14.55
Open 14.50
Day Low/High 14.35 / 14.85
52 Wk Low/High 12.45 / 16.45
Volume 204.14K
Avg Volume 301.00K
Exchange NASDAQ
Shares Outstanding 42.31M
Market Cap 605.00M
EPS 0.50
P/E Ratio 28.53
Div & Yield 0.50 (3.48%)

Latest News

Scott+Scott, Attorneys At Law, LLP Is Investigating Derivative Claims On Behalf Of Shareholders Of Meridian Bioscience, Inc.

Scott+Scott, Attorneys At Law, LLP Is Investigating Derivative Claims On Behalf Of Shareholders Of Meridian Bioscience, Inc.

Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is investigating whether certain directors and officers of Meridian Bioscience, Inc.

The Klein Law Firm Reminds Investors Of Commencement Of A Class Action On Behalf Of Meridian Bioscience, Inc. Shareholders And A Lead Plaintiff Deadline Of January 16, 2018

The Klein Law Firm Reminds Investors Of Commencement Of A Class Action On Behalf Of Meridian Bioscience, Inc. Shareholders And A Lead Plaintiff Deadline Of January 16, 2018

The Klein Law Firm reminds shareholders that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc.

VIVO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Meridian Bioscience, Inc. And A Lead Plaintiff Deadline Of January 16, 2018

VIVO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Involving Meridian Bioscience, Inc. And A Lead Plaintiff Deadline Of January 16, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc.

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of Upcoming Deadline In Class Action Lawsuit And Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of...

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Meridian Bioscience, Inc. And Set A Lead Plaintiff Deadline Of January 16, 2018

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed A Complaint To Recover Losses Suffered By Investors In Meridian Bioscience, Inc. And Set A Lead Plaintiff Deadline Of January 16, 2018

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, Inc.

The Klein Law Firm Notifies Investors Of Commencement Of A Class Action On Behalf Of Meridian Bioscience, Inc. Shareholders And A Lead Plaintiff Deadline Of January 16, 2018

The Klein Law Firm Notifies Investors Of Commencement Of A Class Action On Behalf Of Meridian Bioscience, Inc. Shareholders And A Lead Plaintiff Deadline Of January 16, 2018

The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Meridian Bioscience, Inc.

VIVO EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Meridian Bioscience, Inc. And A Lead Plaintiff Deadline Of January 16, 2018

VIVO EQUITY ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Commencement Of A Class Action Involving Meridian Bioscience, Inc. And A Lead Plaintiff Deadline Of January 16, 2018

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of investors who purchased Meridian Bioscience, Inc.

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Meridian Bioscience, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Meridian Bioscience, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 16, 2018 - VIVO

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders Of Meridian Bioscience, Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 16, 2018 - VIVO

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Meridian Bioscience, Inc.

VIVO LOSS NOTICE: Rosen Law Firm Reminds Meridian Bioscience, Inc. Investors Of Important Deadline In Class Action- VIVO

VIVO LOSS NOTICE: Rosen Law Firm Reminds Meridian Bioscience, Inc. Investors Of Important Deadline In Class Action- VIVO

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Meridian Bioscience, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Meridian Bioscience, Inc.

The Klein Law Firm Reminds Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Meridian Bioscience, Inc.

The Klein Law Firm announces the commencement of an investigation of Meridian Bioscience, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Meridian Bioscience, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Meridian Bioscience, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Meridian Bioscience, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Meridian Bioscience, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Meridian Bioscience, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Meridian Bioscience, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Meridian Bioscience, Inc.

The Klein Law Firm Notifies Investors Of An Investigation Concerning Possible Violations Of Federal Securities Laws By Meridian Bioscience, Inc.

The Klein Law Firm announces the commencement of an investigation of Meridian Bioscience, Inc.

VIVO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Meridian Bioscience, Inc.

VIVO INVESTOR ALERT: The Law Offices Of Vincent Wong Reminds Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Meridian Bioscience, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Meridian Bioscience, Inc.

Reminder - Meridian Bioscience (VIVO) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 11/17/17, Meridian Bioscience Inc. will trade ex-dividend, for its quarterly dividend of $0.125, payable on 11/30/17.

Short Interest Falls 13% For VIVO

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 467,627 share decrease in total short interest for Meridian Bioscience Inc. , to 3,145,924, a decrease of 12.94% since 10/13/2017.

VIVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Meridian Bioscience, Inc.

VIVO SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of Meridian Bioscience, Inc.

The Law Offices of Vincent Wong notifies investors of an investigation concerning whether Meridian Bioscience, Inc.

TheStreet Quant Rating: C+ (Hold)